Lite Strategy (LITS) Other financing activities (2011 - 2022)
Lite Strategy (LITS) posted quarterly Other financing activities of $360000.0 for Q1 2022, up 185.71% year-over-year from $126000.0 in Q1 2021, and up 235.85% quarter-over-quarter from -$265000.0 in Q2 2021.
Lite Strategy (LITS) Other financing activities (2011 - 2022) Analysis & Trends
Lite Strategy's Other financing activities history runs 7 years deep, the most recent figure standing at $360000.0 for Q1 2022.
- In Q1 2022, Other financing activities rose 185.71% year-over-year to $360000.0; the TTM figure through Jun 2023 stood at $360000.0 (up 62.9% YoY), while the FY2024 annual figure was $208000.0, changed N/A from the prior year.
- Other financing activities for Q1 2022 stood at $360000.0, up from -$265000.0 in the prior quarter.
- The five-year high for Other financing activities was $5.2 million in Q4 2019, with the low at -$5.0 million in Q2 2020.
- The 5-year median for Other financing activities is $124000.0 (2020), against an average of $90181.8.
- The sharpest annual moves came in 2018 and 2019: Other financing activities jumped 5490.0% in 2018, then sank 741.43% in 2019.
- Lite Strategy's Other financing activities stood at $1.1 million in 2018, then soared by 365.3% to $5.2 million in 2019, then sank by 99.71% to $15000.0 in 2020, then tumbled by 1866.67% to -$265000.0 in 2021, then jumped by 235.85% to $360000.0 in 2022.
- Business Quant data shows LITS's Other financing activities at $360000.0 in Q1 2022, -$265000.0 in Q2 2021, and $126000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 360,000.00 |
| Mar 31, 2022 | 360,000.00 |
| Jun 30, 2021 | -265,000.00 |
| Jun 30, 2021 | -265,000.00 |
| Mar 31, 2021 | 126,000.00 |
| Mar 31, 2021 | 126,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 124,000.00 |
| Sep 30, 2020 | 124,000.00 |
| Jun 30, 2020 | -5.00 Mn |
| Jun 30, 2020 | -5.00 Mn |
| Dec 31, 2019 | 5.20 Mn |
| Dec 31, 2019 | 5.20 Mn |
| Sep 30, 2019 | 72,000.00 |
| Sep 30, 2019 | 72,000.00 |
| Jun 30, 2019 | -898,000.00 |
| Jun 30, 2019 | -898,000.00 |
| Sep 30, 2018 | 1.12 Mn |
| Sep 30, 2018 | 1.12 Mn |